Remote STATE Training for Insomnia in Older Adults

Inclusion criteria

• Participants who are 65 years of age or older. The inclusion age of ≥ 65 is in accordance with the FDA's Guideline for Industry Studies in Support of Special Populations (Geriatrics ICH-E7), which uses 65 as its cutoff for defining the geriatric population prone to insomnia.
• Participants who have an Insomnia disorder diagnosis per DSM-V.
• Participants who exhibit > 30 minutes sleep onset latency (SOL); and/or > 30 minutes wake after sleep onset (WASO).
• Participants must be a US resident.
• Participants who are fluent English speakers, per self-report, to ensure reasonable neuropsychological results on key assessments.
• Participants must have adequate sensorimotor capacity to perform the program, including visual capacity adequate to read from a computer screen at a normal viewing distance, auditory capacity adequate to understand normal speech, and motor capacity adequate to control a computer mouse or a tablet.

Exclusion criteria

• Participants who score ≥ 4 on the Cognitive Function Index (CFI).
• Participants who self-report vision or hearing difficulties that would interfere with the ability to complete the study tasks.
• Participants with past or present psychosis, schizophrenia, or bipolar disorder. Participants with other untreated psychiatric disorder, including substance abuse/dependence disorders.
• Participants with a seizure disorder.
• Participants with untreated obstructive sleep apnea, diagnosis of other sleep disorders not attributable to a primary sleep regulation problem (e.g., restless legs syndrome).
• Participants with a recent hospitalization, ongoing chemotherapy or other cancer treatment.
• Participants enrolled in a concurrent clinical trial involving an investigational pharmaceutical, nutraceutical, medical device, or behavioral treatment (CBTi) in the last 12-months that could affect the outcome of this study, or concurrent engagement in another insomnia treatment, per self-report. However, participation in standard treatments not known to affect sleep (e.g., occupational therapy) or use of prescribed medications (e.g., anti-depressants) is allowable if stable on medications for > 3 months.
• Participants who are using computer-based cognitive training programs or have used it within a month of the consent date.